These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1829024)

  • 1. Prevention of primary prostate cancer in Lobund-Wistar rats by N-(4-hydroxyphenyl)retinamide.
    Pollard M; Luckert PH; Sporn MB
    Cancer Res; 1991 Jul; 51(13):3610-1. PubMed ID: 1829024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of N-methyl-N-nitrosourea, testosterone, and N-(4-hydroxyphenyl)-all-trans-retinamide on prostate cancer induction in Wistar-Unilever rats.
    McCormick DL; Rao KV; Dooley L; Steele VE; Lubet RA; Kelloff GJ; Bosland MC
    Cancer Res; 1998 Aug; 58(15):3282-8. PubMed ID: 9699656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histogenesis of induced prostate and seminal vesicle carcinoma in Lobund-Wistar rats: a system for histological scoring and grading.
    Slayter MV; Anzano MA; Kadomatsu K; Smith JM; Sporn MB
    Cancer Res; 1994 Mar; 54(6):1440-5. PubMed ID: 8137245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemopreventive activity of tamoxifen, N-(4-hydroxyphenyl)retinamide, and the vitamin D analogue Ro24-5531 for androgen-promoted carcinomas of the rat seminal vesicle and prostate.
    Lucia MS; Anzano MA; Slayter MV; Anver MR; Green DM; Shrader MW; Logsdon DL; Driver CL; Brown CC; Peer CW
    Cancer Res; 1995 Dec; 55(23):5621-7. PubMed ID: 7585644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibitory effect of 4-hydroxyphenyl retinamide (4-HPR) on metastasis of prostate adenocarcinoma-III cells in Lobund-Wistar rats.
    Pollard M; Luckert PH
    Cancer Lett; 1991 Aug; 59(2):159-63. PubMed ID: 1832081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary fenretinide, a synthetic retinoid, decreases the tumor incidence and the tumor mass of ras+myc-induced carcinomas in the mouse prostate reconstitution model system.
    Slawin K; Kadmon D; Park SH; Scardino PT; Anzano M; Sporn MB; Thompson TC
    Cancer Res; 1993 Oct; 53(19):4461-5. PubMed ID: 8402613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of autochthonous prostate cancer in Lobund-Wistar rats by treatments with N-nitroso-N-methylurea and testosterone.
    Pollard M; Luckert PH
    J Natl Cancer Inst; 1986 Aug; 77(2):583-7. PubMed ID: 3461217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary prevention of hormone refractory prostate cancer in Lobund-Wistar rats: a review of studies in a relevant animal model.
    Pollard M; Suckow MA
    Comp Med; 2006 Dec; 56(6):461-7. PubMed ID: 17219775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of short-term administration of N-(4-hydroxyphenyl)-all-trans-retinamide on chemically induced mammary tumors.
    Silverman J; Katayama S; Radok P; Levenstein MJ; Weisburger JH
    Nutr Cancer; 1983; 4(3):186-91. PubMed ID: 6221232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of induced prostate-related cancer by soy protein isolate/isoflavone-supplemented diet in Lobund-Wistar rats.
    Pollard M; Wolter W; Sun L
    In Vivo; 2000; 14(3):389-92. PubMed ID: 10904871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of adenocarcinomas of the dorsolateral prostate induced in Wistar rats by N-methyl-N-nitrosourea, 7,12-dimethylbenz(a)anthracene, and 3,2'-dimethyl-4-aminobiphenyl, following sequential treatment with cyproterone acetate and testosterone propionate.
    Bosland MC; Prinsen MK; Dirksen TJ; Spit BJ
    Cancer Res; 1990 Feb; 50(3):700-9. PubMed ID: 2105161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous vs. intraprostatic administration of N-methyl-N-nitrosourea to induce prostate cancer in rats.
    Schleicher RL; Fallon MT; Austin GE; Zheng M; Zhang M; Dillehay DL; Collins DC
    Prostate; 1996 Jan; 28(1):32-43. PubMed ID: 8545279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-(4-Hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rat.
    Moon RC; Thompson HJ; Becci PJ; Grubbs CJ; Gander RJ; Newton DL; Smith JM; Phillips SL; Henderson WR; Mullen LT; Brown CC; Sporn MB
    Cancer Res; 1979 Apr; 39(4):1339-46. PubMed ID: 421218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of dorsolateral prostate adenocarcinomas and other accessory sex gland lesions in male Wistar rats by a single administration of N-methyl-N-nitrosourea, 7,12-dimethylbenz(a)anthracene, and 3,2'-dimethyl-4-aminobiphenyl after sequential treatment with cyproterone acetate and testosterone propionate.
    Bosland MC; Prinsen MK
    Cancer Res; 1990 Feb; 50(3):691-9. PubMed ID: 2137026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative chemopreventive activity of ibuprofen and N-(4-hydroxyphenyl) retinamide against the development and growth of rat mammary adenocarcinomas.
    Alshafie GA; Harris RE; Robertson FM; Parrett ML; Ross M; Abou-Issa H
    Anticancer Res; 1999; 19(4B):3031-6. PubMed ID: 10652588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostatic localization of spontaneous early invasive carcinoma in Lobund-Wistar rats.
    Pugh TD; Chang C; Uemura H; Weindruch R
    Cancer Res; 1994 Nov; 54(22):5766-70. PubMed ID: 7525050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemopreventive efficacy of combined retinoid and tamoxifen treatment following surgical excision of a primary mammary cancer in female rats.
    Ratko TA; Detrisac CJ; Dinger NM; Thomas CF; Kelloff GJ; Moon RC
    Cancer Res; 1989 Aug; 49(16):4472-6. PubMed ID: 2525951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gross and microscopic pathology of induced prostatic complex tumors arising in Lobund-Wistar rats.
    Cohen MB; Heidger PM; Lubaroff DM
    Cancer Res; 1994 Feb; 54(3):626-8. PubMed ID: 7508335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 9-cis-retinoic acid but not 4-(hydroxyphenyl)retinamide inhibits prostate intraepithelial neoplasia in Noble rats.
    Christov KT; Moon RC; Lantvit DD; Boone CW; Steele VE; Lubet RA; Kelloff GJ; Pezzuto JM
    Cancer Res; 2002 Sep; 62(18):5178-82. PubMed ID: 12234981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced inhibition of mammary carcinogenesis by combined treatment with N-(4-hydroxyphenyl)retinamide and ovariectomy.
    McCormick DL; Mehta RG; Thompson CA; Dinger N; Caldwell JA; Moon RC
    Cancer Res; 1982 Feb; 42(2):508-12. PubMed ID: 6459843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.